PITTSBURGH, June 12th, 2014 — Gateway Analytical announced today that they will be presenting a poster session that focused on using Raman Imaging for chemically specific characterization of Combination Dry Powder Inhalers at the Sixteenth International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS®-16), June 16-19th in Prague, Czech Republic.
PITTSBURGH, April 24th, 2014 — Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo, Puerto Rico, May 4-8. RDD is an international conference that features in-depth presentations and discussions focused on the latest development in respiratory drug delivery science, in addition to industry networking. During the conference Gateway will be promoting their unique Raman chemical imaging services that provide drug developers with truly chemically specific particle characterization. This chemical specificity is the key to understanding the extend of agglomerations in orally inhaled drug products (OINDPs), which is critical for safety, stability and FDA submission.
Gateway Analytical has teamed up with researchers from the Division of Pharmaceutical Analysis at FDA/CDER to present new findings on temperature-mediated agglomeration assessment in Orally Inhaled and Nasal Drug Products. This study was performed to address aqueous nasal spray suspensions stability during long-term shipping/storage. During the study, suspension formulations were subjected to temperatures that may possibly be reached inside shipping containers during hottest and coldest months in St. Louis, MO.
Original Event Date: Wednesday, July 10, 2013
Duration: 60 minutes
Presenters: Oksana Olkhovyk, Ph.D., Senior Scientist at Gateway Analytical
Host: Shawn Wilhelm, Marketing Coordinator at Gateway Analytical
Event Date: Wednesday, September 18, 2013
Time: 11 a.m. EST
Duration: 60 minutes
Presenters: David Exline, Senior Vice President & Rebekah Wagurak, Scientist I at Gateway Analytical
Host: Shawn Wilhelm, Marketing Coordinator at Gateway Analytical
FDA Critical Path Opportunity
Poster Session: Investigating the Miscibility of an API in Soluplus® Dispersions by Raman Chemical Imaging Technique
Date: Tuesday, October 16, 2012
Time: 9:30 am - 12:30 pm
Location: Hall F
During this recent webinar, Dr. Oksana Olkhovyk presented on the benefits of this novel method of particle sizing that automatically measures particle size distribution. She also discussed specific references to FDA bioequivalence guidance documentation, innovative product design and intellectual property benefits.